EU MDR 2017/745 Consulting California

Bringing your medical device to the European market opens the door to more than 400 million patients. EU MDR 2017/745 is the regulation that controls that entry. For California device developers moving beyond FDA clearance, the rules can feel unfamiliar. MedLaunch turns those requirements into clear, manageable steps, so your California-built device reaches European patients on time and to standard.

This page explains what EU MDR 2017/745 means for U.S.-based manufacturers, how it differs from the old rules, and the exact path to CE marking.

What Is EU MDR 2017/745?

EU MDR 2017/745 is the European Union’s Medical Device Regulation. It sets the safety, performance, and quality standards every medical device must meet before it can carry the CE mark and be sold in Europe.

The regulation replaced the older Medical Device Directive (MDD). It raised the bar across the board, with stricter clinical evidence, deeper documentation, and stronger tracking of devices once they reach the market.

Why this matters for California manufacturers:

• Market access: Without EU MDR compliance, you cannot legally sell your device in the European Union.
• Credibility: A CE mark signals to investors, partners, and distributors that your device meets a rigorous global standard.
• Growth: European approval expands your reach far beyond the U.S. market.

FDA clearance does not carry over to Europe. You need a separate, EU-specific pathway, and that pathway starts with EU MDR.

From California to Europe: What U.S. Developers Should Know

California builds some of the world’s most advanced medical technology. Taking that technology to Europe means adjusting to a different regulatory system and a different rhythm of work. A little planning here saves months later.

Working Across Time Zones With Notified Bodies

A Notified Body is the independent organization that reviews and certifies your device for the European market. Most sit in Europe, eight or nine hours ahead of California.

That gap shapes how you work:

• Plan for delayed replies. A question you send at 9 a.m. in San Diego may not get answered until the next business day in Europe.
• Schedule calls early. Morning meetings on the West Coast line up with the European afternoon.
• Front-load your documentation. Complete, well-organized submissions reduce the number of back-and-forth cycles, which matters most when each cycle can cost a day.

MedLaunch manages this cadence for you, keeping your submission moving even when the clock works against you.

Moving From FDA Standards to EU MDR

If your team knows the FDA system, you already understand structured regulatory work. EU MDR uses many of the same building blocks, but with important differences.

• Clinical evidence carries more weight. EU MDR expects strong clinical data for a wider range of devices than the FDA often requires.
• Classification rules differ. A device in one FDA class may fall into a different risk class under EU MDR.
• You need a European representative. Manufacturers outside the EU must appoint an Authorized Representative based in Europe.
• Documentation runs deeper. EU MDR technical files are typically broader and more detailed than a 510(k).

The good news: your existing quality work gives you a strong head start. We help you map what you already have to what Europe expects.

Key EU MDR Changes Compared to the MDD

EU MDR reshaped several core requirements. Here is where the biggest changes land, and what each one means for your submission.

Technical Documentation

Under the MDD, technical files were often lighter. EU MDR demands a complete, structured technical documentation package that fully describes your device.

Your file must cover:

• Device description and intended purpose
• Design and manufacturing information
• Risk management records aligned with ISO 14971
• Verification and validation data
• Labeling and instructions for use

Reviewers expect this documentation to be thorough, current, and easy to follow. Gaps here are among the most common reasons submissions stall.

Clinical Evaluation Reports (CER)

The CER is where EU MDR raised the bar most sharply. This report proves your device is safe and performs as intended, backed by clinical evidence.

Compared to the MDD, EU MDR expects:

• Stronger clinical data, with less reliance on comparisons to similar devices.
• A continuous process, since your CER must stay current across the device’s life.
• Clear links between your clinical evidence, your risk analysis, and your claims.

For many California developers, the CER is the single largest workstream. Starting early pays off.

Post-Market Surveillance (PMS)

EU MDR treats your work after launch as seriously as the work before it. Post-Market Surveillance is your system for tracking real-world performance and acting on what you learn.

A compliant PMS system includes:

• A PMS plan that defines how you collect and review data.
• Periodic Safety Update Reports (PSURs) for higher-risk devices.
• A feedback loop that ties field data back to your risk management and technical file.

This ongoing duty keeps your device compliant long after it reaches European patients.

Your Step-by-Step CE Marking Roadmap

Achieving CE marking under EU MDR follows a clear sequence. Here is the path, broken into manageable steps.

1. Confirm your device qualifies. Verify your product meets the EU definition of a medical device.
2. Determine your risk class. Classify your device (Class I, IIa, IIb, or III) under EU MDR rules, since your class drives the rest of the process.
3. Appoint an Authorized Representative. As a California-based manufacturer, you must name an EU-based representative.
4. Build your quality management system. Put an ISO 13485 aligned QMS in place to support design, production, and monitoring.
5. Compile your technical documentation. Assemble a complete technical file, including your risk management records.
6. Prepare your Clinical Evaluation Report. Gather and document the clinical evidence that supports your device.
7. Engage a Notified Body. For most classes above Class I, an accredited Notified Body reviews and audits your submission.
8. Set up Post-Market Surveillance. Establish your PMS system before you launch, not after.
9. Register in EUDAMED and apply UDI. Register your device and assign Unique Device Identifiers as required.
10. Affix the CE mark and launch. Once certified, you can legally sell your device across the European Union.

Each step builds on the last. A knowledgeable partner keeps the sequence on track and helps you avoid costly rework.

How MedLaunch Guides Your EU MDR Journey

You do not have to work through EU MDR alone. MedLaunch partners with California developers at every stage, turning a demanding regulation into a clear plan. Our support includes:

• Gap Analysis and Strategic Planning: We compare your current systems against EU MDR requirements, then build a customized roadmap that closes gaps and fits your business goals.
• Technical Documentation Support: We help you prepare and review your full technical file, including clinical evaluations, risk assessments, and quality records built to EU MDR standards.
• Post-Market Surveillance Setup: We design robust PMS systems that keep you compliant and ready to respond to field data and regulatory updates.
• Training and Organizational Support: We equip your team with practical knowledge of EU MDR through targeted training and ongoing guidance.

With MedLaunch, you gain a partner who understands both the California starting point and the European destination.

Schedule Your EU MDR Consultation

Ready to bring your device to the European market with confidence? Contact MedLaunch to schedule a consultation. We will review your current position, flag the gaps that matter most, and map a clear path to CE marking and a successful launch in Europe.